Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Oric Pharmaceuticals Inc (NQ: ORIC ) 10.65 +0.29 (+2.80%) Streaming Delayed Price Updated: 4:00 PM EDT, Sep 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 196,302 Open 10.48 Bid (Size) 10.38 (2) Ask (Size) 11.00 (10) Prev. Close 10.36 Today's Range 10.39 - 10.88 52wk Range 5.270 - 16.65 Shares Outstanding 54,532,614 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) September 06, 2024 From ORIC Pharmaceuticals Via GlobeNewswire ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences August 26, 2024 From ORIC Pharmaceuticals Via GlobeNewswire Performance YTD +16.52% +16.52% 1 Month +4.41% +4.41% 3 Month +39.40% +39.40% 6 Month -17.63% -17.63% 1 Year +76.03% +76.03% More News Read More ORIC Stock Earnings: ORIC Pharmaceuticals Misses EPS for Q2 2024 August 12, 2024 Via InvestorPlace ORIC Pharmaceuticals Reports Second Quarter 2024 Financial Results and Operational Updates August 12, 2024 From ORIC Pharmaceuticals Via GlobeNewswire ORIC Pharmaceuticals Expands Leadership Team with the Appointment of Keith Lui as Senior Vice President of Commercial and Medical Affairs August 05, 2024 From ORIC Pharmaceuticals Via GlobeNewswire ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) August 02, 2024 From ORIC Pharmaceuticals Via GlobeNewswire ORIC Pharmaceuticals Announces Multiple Clinical Collaborations with Strategic Partners to Support Ongoing Trial Evaluating ORIC-944 in Combination with AR Inhibitors for the Treatment of Prostate Cancer July 16, 2024 From ORIC Pharmaceuticals Via GlobeNewswire Attovia Therapeutics Announces Election of Mitchell Gold and Angie You to Board of Directors July 09, 2024 From Attovia Therapeutics, Inc. Via GlobeNewswire ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) July 05, 2024 From ORIC Pharmaceuticals Via GlobeNewswire ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) June 07, 2024 From ORIC Pharmaceuticals Via GlobeNewswire ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences May 29, 2024 From ORIC Pharmaceuticals Via GlobeNewswire ORIC Stock Earnings: ORIC Pharmaceuticals Beats EPS for Q1 2024 May 06, 2024 Via InvestorPlace ORIC Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Updates May 06, 2024 From ORIC Pharmaceuticals Via GlobeNewswire ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) May 03, 2024 From ORIC Pharmaceuticals Via GlobeNewswire Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet April 19, 2024 Via Benzinga ORIC Pharmaceuticals Announces First Patients Dosed Across Three Expansion Cohorts in Phase 1b Trial of ORIC-114 in Patients with Mutated NSCLC April 15, 2024 From ORIC Pharmaceuticals Via GlobeNewswire ORIC Pharmaceuticals Presents Preclinical Data on Two Programs at the 2024 American Association for Cancer Research (AACR) Annual Meeting April 08, 2024 From ORIC Pharmaceuticals Via GlobeNewswire ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) April 05, 2024 From ORIC Pharmaceuticals Via GlobeNewswire ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences April 04, 2024 From ORIC Pharmaceuticals Via GlobeNewswire Micron To Rally Around 134%? Here Are 10 Top Analyst Forecasts For Thursday March 21, 2024 Via Benzinga These Analysts Revise Their Forecasts On ORIC Pharmaceuticals After Q4 Results March 12, 2024 Via Benzinga ORIC Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Updates March 11, 2024 From ORIC Pharmaceuticals Via GlobeNewswire ORIC Pharmaceuticals to Present at the Leerink Partners Global Biopharma Conference March 06, 2024 From ORIC Pharmaceuticals Via GlobeNewswire ORIC Pharmaceuticals Announces Multiple Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting March 05, 2024 From ORIC Pharmaceuticals Via GlobeNewswire ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) March 01, 2024 From ORIC Pharmaceuticals Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
